January transfer window: our writers' Premier League predictions
From Serhou Guirassy to Ivan Toney and Dominic Solanke, we assess which players are most likely to be signed or sold this month in our team-by-team guide
Stay updated with breaking news from Gary Jacob. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
From Serhou Guirassy to Ivan Toney and Dominic Solanke, we assess which players are most likely to be signed or sold this month in our team-by-team guide
OKYO Pharma Ltd (NASDAQ:OKYO) told investors that it is on track to release top-line results from its phase 2 clinical trial of OK-101 to treat dry eye...
OKYO Pharma Ltd (NASDAQ:OKYO), the clinical-stage drug developer, told investors it has filed an Investigational New Drug (IND) application with the US Food...
OKYO Pharma Ltd (NASDAQ:OKYO), the clinical-stage drug developer, has reported encouraging safety data for its ongoing phase II clinical trial of OK-101, a...
OKYO Pharma Ltd (NASDAQ:OKYO) announced that it has completed full enrollment of patients in the randomized portion of the Phase 2 multi-center,...